Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Clemens

Showing results (351-360 of 395) with videos related to

Pageof 40
Sort By:
Molecular Genetics and Metabolism|October 4, 2012
Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfaAns T van der Ploeg, Richard Barohn, Lisa Carlson, et al.
The Lancet. Neurology|February 4, 2018
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional managementDavid J Birnkrant, Katharine Bushby, Carla M Bann, et al.
Breast Cancer Research and Treatment|June 14, 2011
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40)Gunter von Minckwitz, Silvia Darb-Esfahani, Sibylle Loibl, et al.
British Journal of Cancer|April 28, 2017
Extended RAS analysis and correlation with overall survival in advanced pancreatic cancerMichael Haas, Steffen Ormanns, Sibylle Baechmann, et al.
Muscle & Nerve|May 9, 2025
Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPELHani Kushlaf, Jordi Díaz-Manera, Drago Bratkovic, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 30, 2014
Batch versus flow photochemistry: a revealing comparison of yield and productivityLuke D Elliott, Jonathan P Knowles, Paul J Koovits, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 studyGunter von Minckwitz, Andreas du Bois, Marcus Schmidt, et al.
Plos One|July 20, 2016
Correction: Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History StudySimina M Boca, Maki Nishida, Michael Harris, et al.
Scientific Reports|August 18, 2016
Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of childrenYetrib Hathout, Laurie S Conklin, Haeri Seol, et al.
Plos Biology|June 12, 2018
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activationJing Zhao, Lei Zhang, Xiaodong Mu, et al.
Pageof 40

Showing results (351-360 of 395) with videos related to

Sort By:
Pageof 40
Molecular Genetics and Metabolism|October 4, 2012
Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfaAns T van der Ploeg, Richard Barohn, Lisa Carlson, et al.
The Lancet. Neurology|February 4, 2018
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional managementDavid J Birnkrant, Katharine Bushby, Carla M Bann, et al.
Breast Cancer Research and Treatment|June 14, 2011
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40)Gunter von Minckwitz, Silvia Darb-Esfahani, Sibylle Loibl, et al.
British Journal of Cancer|April 28, 2017
Extended RAS analysis and correlation with overall survival in advanced pancreatic cancerMichael Haas, Steffen Ormanns, Sibylle Baechmann, et al.
Muscle & Nerve|May 9, 2025
Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPELHani Kushlaf, Jordi Díaz-Manera, Drago Bratkovic, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 30, 2014
Batch versus flow photochemistry: a revealing comparison of yield and productivityLuke D Elliott, Jonathan P Knowles, Paul J Koovits, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 studyGunter von Minckwitz, Andreas du Bois, Marcus Schmidt, et al.
Plos One|July 20, 2016
Correction: Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History StudySimina M Boca, Maki Nishida, Michael Harris, et al.
Scientific Reports|August 18, 2016
Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of childrenYetrib Hathout, Laurie S Conklin, Haeri Seol, et al.
Plos Biology|June 12, 2018
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activationJing Zhao, Lei Zhang, Xiaodong Mu, et al.
Pageof 40